Enter your terms above and click the 'Search' button.

Showing articles 0 to 12 of 12 Filter Applied: monoclonal antibodies (Click to remove) Polymyalgia Rheumatica Lancet 402:1459-1472, Espigol-Frigole,G.,et al, 2023 Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy Neurol 91:e359-e363, Rauer,S.,et al, 2018 Neuromyelitis Optica Spectrum Disorder NEJM 387:631-639, Wingerchuk, D.M. & Lucchinetti, C.F., 2022 Autoimmune Encephalitis Related to Cancer Treatment with Immune Checkpoint Inhibitors Neurol 97:e191-e202, Nersesjan, V.,et al, 2021 Autoimmune Pancerebellitis Associated with Pembrolizumab Therapy Neurol 91:91-93, Vitt, J.R.,et al, 2018 Myasthenia Gravis NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016 Daclizumab-Induced Adverse Events in Multiple Organ Systems in Multiple Sclerosis Neurol 82:984-988, Oh, J.,et al, 2014 Severe Cutaneous Candida Infection During Natalizumab Therapy in Multiple Sclerosis Neurol 74:521-523, Gutwinski,S.,et al, 2010 Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients Medicine 89:166-175, Mu�oz,P., et al, 2010 Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment Neurologist 13:261-271, Tuzun,E. &Dalmau,J., 2007 Infusion-Related Hypersensitivity Reactions During Natalizumab Treatment Neurol 67:1717-1718, Phillips,J.T.,et al, 2006 Diagnostic Importance of Immunological Markers in Lymphoma Involving the Central Nervous System Ann Neurol 16:668-672, Ezrin-Waters,C.,et al, 1984 Showing articles 0 to 12 of 12